Browse all practice questions for the Board Certified Sterile Compounding Pharmacist (BCSCP) Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Board Certified Sterile Compounding Pharmacist (BCSCP) Practice Test course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • Which medium is used for airborne fungi in a high-risk compounded environment at 26-30°C for 5-7 days?
  • What documentation is necessary for AOR?
  • What is the HEPA filter efficiency for capturing 0.3 micron particles?
  • Which characteristic describes 800-C-SEC for HD compounding?
  • High Risk CSP Prep includes a prefiltration pore size of what?
  • Which statement about AOR documentation is true?
  • Sterile HD compounding must be performed in which containment?
  • Does a prefilled syringe with a self-contained system of reconstitution need to be manipulated inside a C-PEC?
  • Which dosage form requires a biocompatible polymeric excipient and may be bioresorbable for extended release?
  • Which ISO class corresponds to ISO Class 100 (Class 100) for room air?
  • What activities are encompassed by handling HDs?
  • If an AOR is not performed, what must be done with HDs?
  • Which flooring description correctly describes SEC floors in a sterile compounding environment?
  • What is the maximum number of packages and entries allowed for a Low Risk CSP?
  • Which statement defines Biological indicators (BI) in sterilization contexts?
  • Which method is the method of choice for sterility testing?
  • How long should calibration, annual maintenance reports, and routine maintenance records be kept?
  • On each package of nonsterile bulk materials used for compounding CSPs, what information must be marked?
  • Which administration activity has potential exposure to HDs?
  • Do inorganic arsenic compounds, including arsenic trioxide, have established standards such as PEL, REL, and TLV?
  • Semiquantitative testing information refers to which of the following?
  • Arsenic trioxide disposal category under RCRA?
  • The first USP Supplement was published in which month?
  • Is product verification a DSCSA requirement?
  • Can NIOSH listed Table 2 or 3 HDs be compounded in a positive pressure C-SEC, and if so, what labeling requirements?
  • Which analytical techniques are most reliable for determining stability when published literature is not available?
  • Which is a compounding exposure activity?
  • Dry Heat Sterilization is performed how?
  • What does API stand for?
  • Under what condition can a positive-pressure C-SEC be used for NIOSH Table 2 or 3 HDs if an AOR is performed?
  • Allergen extracts are administered by which routes?
  • Are there current standards or recommendations for HD exposure amounts?
  • May a CACI, isolator, robotic device etc be used to compound a sterile HD outside a C-SEC?
  • Which dosage form is a liquid preparation of drug substances dissolved or dispersed in a suitable emulsion medium, typically oil-in-water or water-in-oil?
  • What type of C-PEC is required for aseptic HD prep?
  • What is a potential issue when using water-miscible alcohols with filtration?
  • Sterile Powders for Suspension: Consists of drug substances and other components as dry-formulation ingredients to ensure the chemical and physical stability of the presentation within final use container.
  • Which statement best describes the HD exposure standards regarding RELs, PELs, and TLVs?
  • Who is responsible for enforcing USP standards?
  • Which testing information category would include concentration and strength measurements?
  • What is the initial competency requirement for gloved fingertip sampling?
  • Where should HD APIs be handled prior to sterilization when compounding sterile HDs?
  • What best describes a drug-eluting stent?
  • Which statement about actionable organisms in airborne sampling is true?
  • The 351(k) pathway is used for which products?
  • For soluble platinum salts, the OSHA PEL and ACGIH TLV are based on what?
  • When should BSC be field certified?
  • Microparticles are injectable, resorbable microparicles for extended release generally range from 20 to 100 µm in diameter. They consist of drug substances embedded with a biocompatible, bioresorable polymeric excipient.
  • Gloved fingertip sampling plates are incubated at what temperature and duration?
  • For water-containing topical and mucosal liquids, the BUD is not later than how many days?
  • Which option lists all three methods used for testing bacterial endotoxins?
  • Which policy is included for HD waste segregation and disposal?
  • Which of the following is NOT listed as a cause of viable air sample failure?
  • Which item is not typically recommended PPE for HD drug receipt?
  • If the C-PEC cannot maintain ISO 7 in the prep area, in what ISO environment should presterilization procedures be completed?
  • Does USP certify or validate PPE or equipment for HD handling?
  • Under USP guidelines, which arrangement is specified for low- and medium-risk hazardous drug compounding with fixed walls?
  • What does PEL stand for?
  • Which of the following is a route of administration for parenteral drug products?
  • Which of the following is a factor that affects exposure to hazardous drugs (HDs)?
  • What does ACGIH stand for?
  • What does OEL stand for?
  • DSCSA requires an enhanced system to trace products at package level by 2023. Is this statement true?
  • What are the requirements for a CACI located outside ISO7 used for hazardous drugs?
  • Liposomes are aqueous dispersions of amphiphilic lipids organized as lipid bilayer vesicles enclosing an internal aqueous compartment. Which description best matches liposomes?
  • Which statement best describes a compliant Working Environment in sterile compounding?
  • In precision of ACD, what does precision refer to?
  • Which element must be included in an occupational safety plan for hazardous drugs?
  • Quality Assurance is a mechanism for monitoring, evaluating, correcting, and improving activities and processes. How often is QA reassessed?
  • Which of the following is recognized as a High Risk Condition?
  • Growth must be identified to which taxonomic level?
  • What is the minimum PPE requirement when unpacking hazardous drugs?
  • What is the official date associated with the second USP Supplement publication?
  • What is the BUD for ADD-Vantage devices assembled in ISO 5?
  • CSTD requirements are described as follows:
  • Which of the following is an example of a finished dosage form?
  • BLA stands for which regulatory document?
  • What elements are included in the initial baseline assessment for medical surveillance?
  • Which statement reflects a DSCSA requirement that includes multiple components?
  • For water-containing oral formulations, the BUD is not later than how many days when stored at controlled cold temperature?
  • Are sterile and non-sterile HD compounding allowed in the same room?
  • Which term describes quantitative testing information?
  • In preps with volumes exceeding 5 mL, which additive is limited to a maximum of 0.5%?
  • Under USP 800, which drugs do not have to follow USP 800 if an AOR is performed?
  • Which is the most common chemical degradation pathway for CSPs?
  • Under entity policy, which storage allowance is correct?
  • What is USP 800's purpose?
  • USP 800 defines API as which of the following?
  • Medium Risk CSP is characterized by which description?
  • Which of the following is NOT a technique used for bacterial endotoxin testing?
  • Approximately how many US healthcare workers are exposed to hazardous drugs each year?
  • Which ability should personnel trained to operate equipment possess?
  • Which formula converts Fahrenheit to Celsius?
  • The NIOSH list is based on what?
  • Subcutaneous, local ocular delivery or surgically implanted—these are delivery routes for which dosage form?
  • Qualitative testing information includes which of the following?
  • In radiopharmaceutical handling, which arrangement is correct?
  • Are suppliers required to ship HDs in impervious plastic?
  • What incubation time is used for bacteria on Soybean-Casein Digest Medium?
  • For Low Risk CSP with 12-hour BUD, what containment is required?
  • C-PECs used for manipulation of sterile HDs must be:
  • For ISO 5 air, what is the actionable CFU threshold?
  • Gowns may be removed and retained in the compounding area and re-donned during the same work shift only if they are not visibly soiled.
  • An OSHA PEL and an ACGIH TLV have been established for which HD?
  • Regarding Group 1, 2, or 3 assessment of risk, which statement is true?
  • PPE chemo gown material: which provides better protection and should be disposed after each use?
  • Which statement about receiving hazardous drugs is correct?
  • If a CACI or isolator is used for preparation of HDs and is later used for non-HD prep, what labeling requirement applies to the non-HD prep?
  • DSCSA stands for which act?
  • What is recommended regarding field certification labeling on a BSC?
  • Which microbiological medium is used for viable airborne sampling at 30-35°C for 48-72 hours?
  • What is required to show that a gown will resist permeability by HDs?
  • Oil-in-water or water-in-oil emulsions typically entrap the drug substance. This describes which dosage form?
  • What is the BUD for addEASE devices assembled in ISO 5 for 50 and 100 mL bags?
  • C-SEC external ventilation must be:
  • Qualitative testing information would include presence/absence testing and sterility.
  • Which dosage form is defined as a clear, homogeneous liquid dose form that contains one or more chemical substances dissolved in a solvent or a mixture of mutually miscible solvents?
  • Which dosage form comprises injectable, resorbable particles sized roughly 20 to 100 micrometers for extended release?
  • Can the C-PEC be used to create 100% of the external venting for the C-SEC?
  • What is the HEPA filter efficiency for particles as small as 0.3 micron (MPPS)?
  • Depyrogenation by dry heat uses what temperature and time?
  • In preps with volumes exceeding 5 mL, which additive is limited to a maximum of 0.01%?
  • The open architecture limits are described as applicable to which risk categories?
  • In preps with volumes exceeding 5 mL, which additive is limited to a maximum of 0.2%?
  • Which of the following is a component of the occupational safety plan?
  • Who does USP 800 apply to?
  • Is compounding regulated by the FDA?
  • In SEC ceilings, how should the junctures between ceiling and wall be treated to avoid cracks?
  • Which agents are commonly monitored in environmental sampling for HD?
  • In ISO 5 (Class 100) environments, how many 5 µm and larger particulates are allowed per cubic meter?
  • Which statement is true about Biological indicators (BI) in sterilization monitoring?
  • For nonaqueous formulations, the BUD is not later than the earliest expiration day of any API or a maximum of how many months, whichever is earlier?
  • After steam sterilization, CSP should be packaged in which way?
  • Which statement about USP 800 requirements for NIOSH-listed drugs is correct?
  • If CSP has been exposed to temps warmer than labeled limit or to temperatures above 40°C for more than 4 hours, what should be done?
  • Which dosage form consists of drug substances and other components as dry-formulation ingredients to ensure the chemical and physical stability of the presentation within a final use container?
  • Segregated compounding area is designed to minimize cross-contamination during sterile compounding.
  • Which ISO classification is required for sterile HD compounding work areas?
  • Is product identification a DSCSA requirement?
  • Which is an example of an alternative containment strategy under AOR?
  • For ISO 7 environments, what is the actionable surface cfu threshold?
  • For Soybean-Casein Digest Medium, how long should it be incubated for bacteria and for fungi respectively?
  • What is the required ACPH for 800-low & med-risk HD C-SCA?
  • How often must the AOR review be documented?
  • For high-risk CSPs, endotoxin content must not exceed what measure?
  • Compounding documentation should include which records?
  • The term 'About' on labeling indicates what?
  • What is a primary criterion in selecting a sterilization method for CSPs?
  • Which of the following is a designated person requirement?
  • Which of the following best defines the drug-eluting stent?
  • For low-volume HD compounding, what containment is required under 797 guidelines?
  • Within an ISO classified area, where should a hand-washing sink be located relative to the HD buffet room?
  • RCRA stands for?
  • Which statement reflects Bendamustine incompatibility with CSTDs?
  • What is the typical steam sterilization parameter for terminally sterilizing aqueous preparations?
  • What testing data should gown manufacturers provide to prove permeability resistance for HD handling?
  • Endotoxin tolerance levels are typically assessed in which category of testing information?
  • Which statement about hazardous drug sign posting is true?
  • Which dosage form is a liquid dose form that contains solid particles in a state of uniform dispersion?
  • DSCSA requires packaging level tracing by which year?
  • How often is viable airborne particle testing performed?
  • Are PPE and Environmental controls specified in Table 5 of NIOSH required?
  • What is the rate of squamous cell shedding from the human body per hour?
  • For Low Risk CSPs, what is the maximum BUD when stored at room temperature (20-25°C)?
  • Is there a single biological marker that is a good indicator of HD exposure?
  • Which statement is NOT true about High Risk CSP Prep?
  • For high-risk by filtration, what pore size must the filter have?
  • Which statement about AOR documentation is true?
  • Under which circumstances are Class II A2 or B1 allowed for aseptic HD prep?
  • What does WEEL stand for?
  • Which statement describes a requirement for HD storage?
  • Where must water sources and drains be located relative to the C-PEC?
  • Which PPE is required specifically when administering injectable antineoplastic HDs?
  • In a drug-eluting stent, where is the drug substance incorporated?
  • A prefilled syringe with a self-contained system of reconstitution may be considered a final dosage form. This means manipulation inside a C-PEC is not always required.
  • Which are possible health effects of HD exposure?
  • Low-volume HD prep can be performed with which arrangement?
  • How should bulk hazardous drugs (HD) be disposed?
  • What incubation time is used for fungi on Soybean-Casein Digest Medium?
  • Implants for extended release consist of a matrix of drug substance and polymeric excipient that may or may not have an outer rate-controlling membrane. The polymeric excipient must be biocompatible but may or may not be bioresorable. They are used for subcutaneous, local ocular delivery or surgically implanted.
  • The second USP Supplement was published in which month?
  • Does OSHA hazard communication standard mandate evaluation of every marketed drug?
  • Do inorganic arsenic and arsenic trioxide have established standards?
  • Large volume injections are defined as which of the following?
  • Environmental sampling for HD is conducted at what frequency?
  • Open architecture relies on a specific airflow velocity. What is this velocity?
  • If nonHD prep is performed in the same C-PEC as an HD prep, which procedure is required?
  • What has to be disposed of at RCRA permitted incinerator?
  • During media fill testing, incubation temperatures include which range?
  • In accuracy of ACD, what is the small-volume range?
  • Which act is cited as part of the biosimilars regulatory context in the source?
  • TLV stands for what?
  • What is the BUD for Mini-Bag Plus 50 mL or 100 mL bags?
  • What constitutes trace waste?
  • Does NIOSH apply to workers in the drug manufacturing sector?
  • Which of the following is a requirement for the low risk area regarding windows/doors?
  • Which element is NOT part of the baseline data collection for medical surveillance?
  • Soybean-Casein Digest Medium is incubated at which temperature range?
  • Which item is NOT listed as a NIOSH criterion for hazardous drugs?
  • Which HDs were detected in the urine of healthcare workers?
  • Compounding documentation should be retained for the same period as prescriptions under state law. Which option reflects this retention?
  • Which color containers are used for trace waste?
  • Small volume injections are defined as volumes of how many milliliters or less?
  • What is the beyond-use date (BUD) for segregated compounding area CSP?
  • If ceiling panels are inlaid, what treatment is required to render them impervious and secure?
  • Which statement best lists those who may be exposed to HDs?
  • For pre-sterilization procedures such as weighing and mixing, the C-PEC must be:
  • Which of the following is a parenteral route of administration?
  • Adverse events and defects must be reported to which programs?
  • How can a CSTD be chemically incompatible with a HD?
  • In Low Risk CSP, which category is associated with 12-hour BUD?
  • For Soybean-Casein Digest Medium, which of the following statements is accurate?
  • Which product is covered by DSCSA Section 581(13)?
  • What describes the limits of open architecture in sterile compounding?
  • Which item is explicitly included as part of the occupational safety plan?
  • What should be done before removing HD drug prep from the C-PEC?
  • What is the maximum beyond-use date for multidose vials (MDV) according to standard sterile compounding guidelines?
  • In situ Gels are liquid preparations intended for injection into specific therapeutic targets. Typically they consist of polymers in organic solvents, and upon injection the solvents migrate away from the site, leaving a gelled mass.
  • What is the preferred method of volumetric air sampling?
  • Packages lacking supplier expiration dates cannot be used after how long unless inspection or testing indicates purity?
  • Which dosage form is described as unique drug products that can be either solutions or suspensions, and are aqueous dispersions of amphiphilic lipids organized as bilayer vesicles enclosing an internal aqueous compartment?
  • Substance identification is part of which testing information category?
  • Endotoxin reduction verification for depyrogenation uses endotoxin challenge vials to verify cycle achieving which log reduction?
  • An AOR is performed for which purpose?
  • What does TLV stand for in occupational exposure terms?
  • What does REL stand for?
  • Media-Fill Testing: How often must it be performed?
  • Which statement is true about the location of a Low Risk CSP area relative to other spaces?
  • What is the maximum beyond-use date for a sterile dose vial (SDV) when opened in air worse than ISO 5?
  • Which activity has potential for HD exposure?
  • What factors are considered in the risk assessment for hazardous drugs?
  • Which individuals may potentially be exposed to HDs?
  • Which statement accurately describes USP 800's scope?
  • NIOSH recommendations for HD receipt include which PPE?
  • Which of the following is a factor affecting exposure to hazardous drugs?
  • Cyclophosphamide surface contamination above which threshold has been associated with human uptake?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy